-
Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges
Author: Yu, Ying; Yang, Yehao; Li, Hui; Fan, Yun
Journal: CANCER TREATMENT REVIEWS. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.ctrv.2023.102520
-
Targeting protein kinases to reverse multidrug resistance in sarcoma.
Author: Chen H, Shen J, Choy E, Hornicek FJ, Duan Z.
Journal: Cancer Treat Rev. 2016 Feb;43:8-18. doi: 10.1016/j.ctrv.2015.11.011. Epub 2015 Dec 8. Review.
-
Personalized therapy for hepatocellular carcinoma: Where are we now?
Author: Chan SL, Wong AM, Lee K, Wong N, Chan AK.
Journal: Cancer Treat Rev. 2016 Apr;45:77-86. doi: 10.1016/j.ctrv.2016.02.008. Epub 2016 Mar 2. Review.
-
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Author: Paolo Pronzato
Journal: Cancer Treatment Reviews, 2016.
-
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Author: Francesca Poggio
Journal: Cancer Treatment Reviews, 2016.
-
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Author: Matteo Lambertini
Journal: Cancer Treatment Reviews, 2016.
-
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Author: Giovanni Rossi
Journal: Cancer Treatment Reviews, 2016.
-
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients
Author: Lucia Del Mastro
Journal: Cancer Treatment Reviews, 2016.
